Literature DB >> 26450782

Editor's Choice- Gender difference in prognostic impact of in-hospital bleeding after myocardial infarction - data from the SWEDEHEART registry.

Anna Holm1, Sofia Sederholm Lawesson1, Eva Swahn2, Joakim Alfredsson1.   

Abstract

BACKGROUND: Bleeding complications increase mortality in myocardial infarction patients. Potential gender difference in bleeding regarding prevalence and prognostic impact is still controversial.
OBJECTIVES: Gender comparison regarding incidence and prognostic impact of bleeding in patients hospitalised with myocardial infarction during 2006-2008.
METHODS: Observational study from the SWEDEHEART register. Outcomes were in-hospital bleedings, in-hospital mortality and one-year mortality in hospital survivors.
RESULTS: A total number of 50,399 myocardial infarction patients were included, 36.6% women. In-hospital bleedings were more common in women (1.9% vs. 3.1%, p<0.001) even after multivariable adjustment (odds ratio (OR) 1.17, 95% confidence interval (CI) 1.01-1.37). The increased risk for women was found in ST-elevation myocardial infarction (OR 1.46, 95% CI 1.10-1.94) and in those who underwent percutaneous coronary intervention (OR 1.80, 95% CI 1.45-2.24). In contrast the risk was lower in medically treated women (OR 0.79, 95% CI 0.62-1.00). After adjustment, in-hospital bleeding was associated with higher risk of one-year mortality in men (OR 1.35, 95% CI 1.04-1.74), whereas this was not the case in women (OR 0.97, 95% CI 0.72-1.31).
CONCLUSIONS: Female gender is an independent risk factor of in-hospital bleeding after myocardial infarction. A higher bleeding risk in women appeared to be restricted to invasively treated patients and ST-elevation myocardial infarction patients. Even though women have higher short- and long-term mortality, there was no difference between the genders among bleeders. After multivariable adjustment the prognostic impact of bleeding complications was higher in men. © The European Society of Cardiology 2015.

Entities:  

Keywords:  Myocardial infarction; bleeding; gender; prognosis

Mesh:

Substances:

Year:  2015        PMID: 26450782     DOI: 10.1177/2048872615610884

Source DB:  PubMed          Journal:  Eur Heart J Acute Cardiovasc Care        ISSN: 2048-8726


  2 in total

1.  Bleeding complications with clopidogrel or ticagrelor in ST-elevation myocardial infarction patients - A real life cohort study of two treatment strategies.

Authors:  Joakim Alfredsson; Kime Omar; József Csog; Dimitrios Venetsanos; Magnus Janzon; Mattias Ekstedt
Journal:  Int J Cardiol Heart Vasc       Date:  2020-03-12

2.  Long term risk and costs of bleeding in men and women treated with triple antithrombotic therapy-An observational study.

Authors:  Anna Holm; Martin Henriksson; Joakim Alfredsson; Magnus Janzon; Therese Johansson; Eva Swahn; Dominique Vial; Sofia Sederholm Lawesson
Journal:  PLoS One       Date:  2021-03-25       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.